Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Azacitidine, Venetoclax Combined with Chidamide (ABC-14 Regimen) As an Induction Therapy for Newly Diagnosed AML: A Real-World Retrospective Analysis By the ABC-14 Collaboration Group

Blood (2024) 144 (Supplement 1): 6014.

https://doi.org/10.1182/blood-2024-210211

Published: 2024

Journal Articles

MRD-Driven Prophylactic or Pre-Emptive Intervention with Chidamide-Based Treatment for High-Risk AML Relapse Post-Transplantation: A Real-World Experience from a Chinese Single Center

Ping Wu, Wei Ling, Chengwei Luo Luo, Lisi Huang, Ruohao Xu, Xiaoling Liang, Jiaqi Tan, Jinghua Wang, Peilong Lai, Suijing Wu, Birong Li, Haijie Huang, Suxia Geng, Xin Du, Jianyu Weng

Blood (2024) 144 (Supplement 1): 1575.

https://doi.org/10.1182/blood-2024-210697

Published: 2024

Journal Articles

Chidamide-Based Pre-Emptive Treatment for High-Risk AML Patients after Hematopoietic Stem Cell Transplantation: A Real-World Experience from Chinese Single-Center

Ping Wu, Wei Ling, Chengwei Luo, Xiaomei Chen, Lisi Huang, Jinghua Wang, Peilong Lai, Suijing Wu, Xin Du, Jianyu Weng

Blood (2023) 142 (Supplement 1): 2890.

https://doi.org/10.1182/blood-2023-187924

Published: 2023

Journal Articles

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Peilong Lai, Mingyan Wu, Minming Li, Chengxin Deng, Zesheng Lu, Chenwei Luo, Xin Huang, Pengjun Liao, Lisi Huang, Ping Wu, Wang Yulian, Changchun Wan, Wei Ling, Liye Zhong, Suijing Wu, Xin Du, MD PhD, Jianyu Weng, MD

Blood (2018) 132 (Supplement 1): 5229.

https://doi.org/10.1182/blood-2018-99-116234

Published: 2018

Journal Articles

Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant

Lisi Huang, Xin Du, Jianyu Weng, MD, Peilong Lai, Zesheng Lu, Ping Wu, Suijing Wu, PhD, Chengwei Luo, Xin Huang, Suxia Geng

Blood (2015) 126 (23): 2118.

https://doi.org/10.1182/blood.V126.23.2118.2118

Published: 2015

Journal Articles

Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia

Xiaomei Chen, Jianyu Weng, Yulian Wang, Chengxin Deng, Chengwei Luo, Pengjun Liao, Minming Li, Xin Huang, Peilong Lai, Lisi Huang, Zhi Cao, Changchun Wan, Liye Zhong, Suijing Wu, Zesheng Lu, Xiaoli Zou, Xin Du

Blood (2015) 126 (23): 4897.

https://doi.org/10.1182/blood.V126.23.4897.4897

Published: 2015

Journal Articles

Blocking Stat3 to Regulate the Balance of Th17/Treg in Cgvhd Therapy

Jianyu Weng, Xin Huang, Xiaomei Chen, Qiong Luo, Jianhua Su, Jiaqi Tong, Zhi Cao, Peilong Lai, Suijing Wu, Chengwei Luo, Wei Ling, Xin Du

Blood (2015) 126 (23): 5420.

https://doi.org/10.1182/blood.V126.23.5420.5420

Published: 2015

Journal Articles

Persistent Clonal Expansion of Vδ3 and Vδ4 T Cells in T-ALL Case with Minimal Residual Disease after HSCT

Ling Xu, Jianyu Weng, PhD, Xin Huang, Shaohua Chen, Suxia Geng, Lijian Yang, Suijing Wu, PhD, Suming Huang, PhD, Du Xin, PhD, Yangqiu Li, MD

Blood (2014) 124 (21): 5885.

https://doi.org/10.1182/blood.V124.21.5885.5885

Published: 2014

Journal Articles

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Jianyu Weng, MD, Xin Huang, Suxia Geng, Chengwei Luo, Suijing Wu, Wei Ling, Rong Guo, Zesheng Lu, Chengxin Deng, Pengxiang Andy, Xin Du

Blood (2012) 120 (21): 4673.

https://doi.org/10.1182/blood.V120.21.4673.4673

Published: 2012

Journal Articles

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Peilong Lai, Jianyu Weng, Chenwei Luo, Rong Guo, Zesheng Lu, Suxia Geng, Xin Du, PhD, Suijing Wu

Blood (2011) 118 (21): 4086.

https://doi.org/10.1182/blood.V118.21.4086.4086

Published: 2011

Journal Articles

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Jianyu Weng, MD, Xin Du, PhD, Suxia Geng, MD, Maohua Zhou, MD, Yanwen Peng, Zhen Wang, Zesheng Lu, Suijing Wu, MD, Chenwei Luo, MD, Rong Guo, PhD, Wei Ling, PhD, Chengxin Deng, Pengjun Liao, Andy Peng Xiang, Ph.D

Blood (2009) 114 (22): 4501.

https://doi.org/10.1182/blood.V114.22.4501.4501

Published: 2009

Journal Articles

Distribution of Cytoskeleton Protein Nestin in Acute Leukemia.

Xin Du, PhD, Xuhui Yang, PhD, Wei Ling, PhD, Xia Tian, Maoxian Zou, Zhengguang Chen, Tao Wang, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Xiuming Zhang, Bruce T. Lahn, Andy Peng Xiang, PhD

Blood (2009) 114 (22): 4721.

https://doi.org/10.1182/blood.V114.22.4721.4721

Published: 2009

Journal Articles

Analysis of TCR Vgamma and Vdelta Repertoire and Clonality of T Cells in MDS Patients.

SuXia Geng, MD, Xin Du, PhD, Yangqiu Li, PhD, Jianyu Weng, MD, Liye Zhong, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD

Blood (2009) 114 (22): 4833.

https://doi.org/10.1182/blood.V114.22.4833.4833

Published: 2009

Journal Articles

Analysis of the Immunophenotypic Features of Blast Cells, Lymphocytes and Granulocytes by Multiparametric Flow Cytometry in Bone Marrow (BM) Cells of Myelodysplastic Syndromes.

Xin Du, PhD, Jing Huang, MD, Maohua Zhou, MD, SuXia Geng, MD, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD, Miaorong She, PhD

Blood (2009) 114 (22): 4843.

https://doi.org/10.1182/blood.V114.22.4843.4843

Published: 2009

Journal Articles

Differential Protein Expression of Serum in Patients with RAEB Myelodysplastic Syndromes.

Liye Zhong, Tianhao Liu, Yangqiu Li, PhD, Suxia Geng, Zesheng Lu, Jianyu Weng, Suijing Wu, Xin Du, PhD

Blood (2009) 114 (22): 4845.

https://doi.org/10.1182/blood.V114.22.4845.4845

Published: 2009

Journal Articles

Analysis of Clinical Characterization of CMML.

Suijing Wu, MD, Xin Du, PhD, Wei Lin, Zilun Huang, Jianyu Weng, MD, Zhixin Huang, Maohua Zhou, MD, Jianhua Su, Zesheng Lu

Blood (2009) 114 (22): 4853.

https://doi.org/10.1182/blood.V114.22.4853.4853

Published: 2009

Journal Articles

Expression and Clinical Significance of Antiapoptotic Gene Aven in De Novo acute Myeloid Leukemia Patients.

SuXia Geng, MD, Xin Du, PhD/MD, Jianyu Weng, MD, Liye Zhong, MD, Rong Guo, PhD, Zesheng Lu, MD, Suijing Wu, MD

Blood (2009) 114 (22): 4132.

https://doi.org/10.1182/blood.V114.22.4132.4132

Published: 2009

Journal Articles

Using Multiparametric Flow Cytometry to Analysis the Immunophenotypic Abnormalities of Bone Marrow Cells in Patients with MDS-RAEB.

Jing Huang, MD, Xin Du, PhD, Suxia Geng, MD, Maohua Zhou, MD, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD, Miaorong She, PhD

Blood (2009) 114 (22): 4856.

https://doi.org/10.1182/blood.V114.22.4856.4856

Published: 2009

Journal Articles

Efficacy and Safety of Gemtuzumab-Based Regimens in Patients with CD33-Positive Refractory Leukemia.

Suijing Wu, MD, Xin Du, MD, PhD, Wei Lin, MD, Jianyu Weng, MD, Jianjun Zhang, MD, Maohua Zhou, MD, Zhixin Huang, MD, Jianhua Su, MD, Zilun Huang, MD, Zesheng Lu, MD

Blood (2007) 110 (11): 4358.

https://doi.org/10.1182/blood.V110.11.4358.4358

Published: 2007

NARROW

Azacitidine, Venetoclax Combined with Chidamide (ABC-14 Regimen) As an Induction Therapy for Newly Diagnosed AML: A Real-World Retrospective Analysis By the ABC-14 Collaboration Group

MRD-Driven Prophylactic or Pre-Emptive Intervention with Chidamide-Based Treatment for High-Risk AML Relapse Post-Transplantation: A Real-World Experience from a Chinese Single Center

Chidamide-Based Pre-Emptive Treatment for High-Risk AML Patients after Hematopoietic Stem Cell Transplantation: A Real-World Experience from Chinese Single-Center

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant

Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia

Blocking Stat3 to Regulate the Balance of Th17/Treg in Cgvhd Therapy

Persistent Clonal Expansion of Vδ3 and Vδ4 T Cells in T-ALL Case with Minimal Residual Disease after HSCT

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Distribution of Cytoskeleton Protein Nestin in Acute Leukemia.

Analysis of TCR Vgamma and Vdelta Repertoire and Clonality of T Cells in MDS Patients.

Analysis of the Immunophenotypic Features of Blast Cells, Lymphocytes and Granulocytes by Multiparametric Flow Cytometry in Bone Marrow (BM) Cells of Myelodysplastic Syndromes.

Differential Protein Expression of Serum in Patients with RAEB Myelodysplastic Syndromes.

Analysis of Clinical Characterization of CMML.

Expression and Clinical Significance of Antiapoptotic Gene Aven in De Novo acute Myeloid Leukemia Patients.

Using Multiparametric Flow Cytometry to Analysis the Immunophenotypic Abnormalities of Bone Marrow Cells in Patients with MDS-RAEB.

Efficacy and Safety of Gemtuzumab-Based Regimens in Patients with CD33-Positive Refractory Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only